Neurofilament Light Chain as a Potential Marker in Behcet's Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-01-01

Study Completion Date

2024-11-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To determine the role of neurofilament light chain in Behçet's disease with or without neurological affection and its relation to neurological manifestation (either peripheral or central ).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Longitudinal Assessment of Protein Markers in the Cerebrospinal Fluid of Patients With Central Nervous System Involvement

NCT07313098

Neurologic Disorder Central Nervous System Diseases

NOT_YET_RECRUITING

The Fingerprinting of Inherited Leukoencephalopathies: A New Brain Imaging, Genetic and Clinical Assessment

NCT06332625

Leukoencephalopathies

RECRUITING

Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders

NCT05982925

Multiple Sclerosis Neuromyelitis Optica Demyelinating Autoimmune Diseases, CNS

ENROLLING_BY_INVITATION

Therapeutic Imaging Biomarkers for Amyotrophic Lateral Sclerosis

NCT02058732

Amyotrophic Lateral Sclerosis

TERMINATED NA

Leucoaraiosis and Multimodal MRI With Fingerprinting Technique

NCT06181981

Leukoaraiosis Magnetic Resonance Imaging

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Behçet disease is a multisystemic autoinflammatory disorder characterized by recurrent oral and genital ulcer, eye affection, thrombosis and many systems can be affected with the most serious being the nervous system affection which is commonly called neuro-Behçet's disease (NBD) In Ghita et al, the prevalence of Behcet disease in Egypt was estimated to be 3.6/100,000 with CNS affection occurred in about 13.1% of the patients , while in other study performed in Egypt the peripheral neuropathy affection reached 53.3% of the patients with insignificant difference between both upper and lower limb but sensory affection was manifested more than motor affection in those patients.

Neurofilament light chain (NFL) is a neuronal cytoplasmic protein, which was assumed to have a role as a prognostic biomarker in several neuroimmunological and neurodegenerative diseases. It was documented in peripheral nerve affection of patients with diabetes mellitus and GuillainBarré syndrome. Recently, some studies documented the presence of high level of NFL chain in serum of neurolupus and primary sjogren's diseases , more over in 2022, Karaaslan et al. measured NFL in the cerebrospinal fluid (CSF) and found it high in neurobehcet patients and assumed that it can predict the prospective cognitive and somatic disability in NBD patients.

So, the investigators aim at our study to assess the role of NFL chain in serum of behcet disease in those with and without peripheral and central nervous system affection and its relation to neurological manifestation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Behçet

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

serum sample and nerve conduction study and cerebrospinal fluid study

serum sample and cerebrospinal fluid study to detect Neurofilament light chain Nerve conduction study

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* any adult patient satisfied International study group criteria of Behcet's disease

Exclusion Criteria

* Patients with definite diagnosis for any other causes affecting central and peripheral nervous system eg….

1. Infection (Viral, Bacterial, Fungal)
2. Toxic
3. Drug induced
4. Other diseases (Multiple sclerosis, Neuromyelitis Optica)
5. Trauma
6. other autoimmune diseases
7. Diabetic patients
8. purely degenerative diseases
9. Tumours

Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No